Search results
With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock?
Motley Fool· 7 months agoThe Food and Drug Administration (FDA) just approved the updated Omicron-adapted COVID-19 booster...
Undervalued Biotech Stocks Shine: Pfizer and BioNTech Show Resilience
GuruFocus.com via Yahoo Finance· 7 months agoIn the ever-evolving world of the stock market, uncovering potential gold mines is paramount for...
Pfizer (PFE), BioNTech Post Data on COVID Jab for Kids Under 5
Zacks via Yahoo Finance· 2 years agoPfizer PFE and partner BioNTech BNTX announced newly-updated data from a phase II/III study,...
Pfizer Hikes Paxlovid Price To $1,390 — More Than Double What The Government Paid
Investor's Business Daily· 6 months agoPfizer is hiking its Paxlovid price to $1,390 for a five-day course — more than double what the U.S....
Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion
Investor's Business Daily· 7 months agoModerna stock and BioNTech led a sell-off Monday among Covid vaccine makers after Pfizer slashed...
Pfizer (PFE), BioNTech Seek EU Nod for Omicron-Based Booster
Zacks via Yahoo Finance· 2 years agoPfizer (PFE) and BioNTech (BNTX) complete submission of conditional marketing authorization to the...
Pfizer COVID vaccine price hike to boost revenue for years, rivals may follow
Reuters via Yahoo Finance· 2 years ago(Reuters) -Pfizer's plan to as much as quadruple U.S. prices for its COVID-19 vaccine next year is...
Covid Stocks Pfizer, Moderna, Novavax Face Their Next Challenge, And It's Worth Billions
Investor's Business Daily· 2 years agoThe Biden administration is planning to stop paying for Covid vaccines and treatments, shifting the...
Pfizer (PFE) Gets FDA Nod for Bivalent COVID Jab in Infants
Zacks via Yahoo Finance· 1 year agoPfizer (PFE) and partner BioNTech receive FDA label expansion to use their Omicron BA.4/BA.5-adapted...
Pfizer (PFE) Q4 Earnings Top, 2023 View Disappoints, Stock Down
Zacks via Yahoo Finance· 1 year agoPfizer PFE reported fourth-quarter 2022 adjusted earnings per share of $1.14, which significantly...